The Cochrane Collaboration issued a podcast reviewing varenicline (Champix, Chantix) and bupropion. They review clinical trials, safety concerns among other relevant aspects. Nicotine receptor partial agonists for smoking cessation Read a related post defining partial agonists.
Health Canada has issued an information update about varenicline (Champix), giving some recommendations to patients: Information Update 2009-01 January 6, 2009 For immediate release OTTAWA – Health Canada is reminding Canadians who are taking, or considering taking, the smoking-cessation aid Champix of important safety information for this product. Health Canada is also informing Canadians that […]
The Medicines and Healthcare products Regulatory Agency has issued recommendations about the use of varenicline (Champix) as a smoking cessation drug. Advice for healthcare professionals: • Patients and their family or care-givers should be made aware of the possibility that trying to stop smoking might cause symptoms of depression • Patients who are taking varenicline […]